BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 25697807)

  • 1. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
    Stulak JM; Tchantchaleishvili V; Haglund NA; Davis ME; Schirger JA; Cowger JA; Shah P; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 May; 34(5):718-23. PubMed ID: 25697807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of concomitant mitral valve repair for severe mitral regurgitation at the time of continuous-flow left ventricular assist device insertion.
    Sandoval E; Singh SK; Carillo JA; Baldwin ACW; Ono M; Anand J; Frazier OH; Mallidi HR
    Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):620-623. PubMed ID: 28962504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of concomitant mitral valve procedures for severe mitral regurgitation during left ventricular assist device implantation.
    Kawabori M; Kurihara C; Conyer RT; Critsinelis AC; Sugiura T; Rosengart T; Morgan JA
    J Artif Organs; 2019 Jun; 22(2):91-97. PubMed ID: 30361785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Baseline Mitral Regurgitation on Postoperative Outcomes After Left Ventricular Assist Device Implantation as Destination Therapy.
    Okoh A; Yanagida R; Schultheis M; Chaudari S; Fugar S; Nnaoma C; Chan O; Zucker MJ; Karanam R; Russo MJ; Camacho M
    Transplant Proc; 2019 Apr; 51(3):859-864. PubMed ID: 30979476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation.
    Kitada S; Kato TS; Thomas SS; Conwell SD; Russo C; Di Tullio MR; Farr M; Schulze PC; Uriel N; Jorde UP; Takayama H; Naka Y; Homma S; Mancini DM
    J Heart Lung Transplant; 2013 Sep; 32(9):897-904. PubMed ID: 23850122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant tricuspid valve surgery during implantation of continuous-flow left ventricular assist devices: a Society of Thoracic Surgeons database analysis.
    Robertson JO; Grau-Sepulveda MV; Okada S; O'Brien SM; Matthew Brennan J; Shah AS; Itoh A; Damiano RJ; Prasad S; Silvestry SC
    J Heart Lung Transplant; 2014 Jun; 33(6):609-17. PubMed ID: 24661682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival.
    Tanaka A; Onsager D; Song T; Cozadd D; Kim G; Sarswat N; Adatya S; Sayer G; Uriel N; Jeevanandam V; Ota T
    Ann Thorac Surg; 2017 Mar; 103(3):725-733. PubMed ID: 27659599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of aortic insufficiency during long-term axial continuous-flow left ventricular assist device support.
    Cowger JA; Aaronson KD; Romano MA; Haft J; Pagani FD
    J Heart Lung Transplant; 2014 Dec; 33(12):1233-40. PubMed ID: 25108909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.
    Morgan JA; Brewer RJ; Nemeh HW; Murthy R; Williams CT; Lanfear DE; Tita C; Paone G
    ASAIO J; 2012; 58(6):574-7. PubMed ID: 23103696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure.
    Tang PC; Haft JW; Romano MA; Bitar A; Hasan R; Palardy M; Wu X; Aaronson KD; Pagani FD
    J Thorac Cardiovasc Surg; 2020 Mar; 159(3):897-905.e4. PubMed ID: 31101350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Concomitant Mitral Valve Surgery With LVAD Placement: Systematic Review and Meta-Analysis.
    Choi JH; Luc JGY; Moncho Escrivá E; Phan K; Rizvi SSA; Patel S; Entwistle JW; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2018 Dec; 42(12):1139-1147. PubMed ID: 30101551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversibility of severe mitral valve regurgitation after left ventricular assist device implantation: single-centre observations from a real-life population of patients.
    Dobrovie M; Spampinato RA; Efimova E; da Rocha E Silva JG; Fischer J; Kuehl M; Voigt JU; Belmans A; Ciarka A; Bonamigo Thome F; Schloma V; Dmitrieva Y; Lehmann S; Hahn J; Strotdrees E; Mohr FW; Garbade J; Meyer AL
    Eur J Cardiothorac Surg; 2018 Jun; 53(6):1144-1150. PubMed ID: 29351635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
    McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial.
    Kanwar MK; Rajagopal K; Itoh A; Silvestry SC; Uriel N; Cleveland JC; Salerno CT; Horstmanshof D; Goldstein DJ; Naka Y; Bailey S; Gregoric ID; Chuang J; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Jun; 39(6):529-537. PubMed ID: 32279919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of Mitral Regurgitation With Left Ventricular Assist Device Support.
    Goodwin M; Nemeh HW; Borgi J; Paone G; Morgan JA
    Ann Thorac Surg; 2017 Sep; 104(3):811-818. PubMed ID: 28527962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.